Dr. Andreas Reitmeier, an investor, reports

On Dec. 19, 2023, Dr. Andreas Reitmeier acquired ownership of an additional 10 million common shares of Rome Resources Ltd. at a deemed price of 25 cents per share pursuant to the exercise, by Rome Resources, of the second option in a property option agreement for an aggregate deemed consideration of $2.5-million.

Prior to the issuance of the shares, Dr. Reitmeier had ownership and control, directly and indirectly, of 13.75 million common shares and 1.5 million share purchase warrants of Rome Resources, representing approximately 15.2 per cent of the then issued and outstanding common shares of Rome Resources on a non-diluted basis and 16.6 per cent when assuming exercise of all share purchase warrants held by Dr. Reitmeier. The acquisition of the shares by Dr. Reitmeier gives him ownership and control, directly and indirectly, of a total of 23.75 million common shares of Rome Resources, an increase of approximately 4.1 per cent, for a total of approximately 19.7 per cent of the issued and outstanding common shares of Rome Resources on a non-diluted basis and 20.7 per cent when assuming exercise of all share purchase warrants held by Dr. Reitmeier.

Dr. Reitmeier's acquisition was made for investment purposes. Dr. Reitmeier may in the future wish to increase or decrease his shareholdings in Rome Resources as circumstances warrant. Such circumstances may include, but are not limited to, compliance with applicable securities laws, general market and economic conditions, business prospects of Rome Resources, and investment and business opportunities available to Dr. Reitmeier. The head office of Rome Resources is located at Suite 700, 688 W Hastings St., Vancouver, B.C., V6B 1P1. A copy of Dr. Reitmeier's early warning report filed under National Instrument 62-103 may either be obtained under Rome Resources' profile on SEDAR+ or by contacting Dr. Reitmeier at 971-50-76-52-56-9.